Significance Statement: Here we elucidate the full biosynthetic pathway of the fungal natural 40 product mycophenolic acid (MPA), which represents an unsolved mystery for decades. Besides the 41 intriguing enzymatic mechanisms, we reveal that the MPA biosynthetic enzymes are elegantly 42 compartmentalized; and the subcellular localization of the acyl-CoA hydrolase MpaH' in 43
Abstract: Mycophenolic acid (MPA) from filamentous fungi is the first natural product antibiotic 21 in human history and a first-line immunosuppressive drug for organ transplantations and 22 autoimmune diseases. However, its biosynthetic mechanisms have remained a long-standing 23 mystery. Here, we elucidate the MPA biosynthetic pathway that features both compartmentalized 24 enzymatic steps and unique cooperation between biosynthetic and β-oxidation catabolism 25 machineries based on targeted gene inactivation, feeding experiments in heterologous expression 26 hosts, enzyme functional characterization and kinetic analysis, and microscopic observation of whole pathway is elegantly co-mediated by these compartmentalized enzymes, together with the 34 peroxisomal β-oxidation machinery. Beyond characterizing the remaining outstanding steps of the peroxisomes is required for the unique cooperation between biosynthetic and β-oxidation 44 catabolism machineries. This work highlights the importance of a cell biology perspective for 45 understanding the unexplored organelle-associated essential catalytic mechanisms in natural 46 product biosynthesis of fungi and other higher organisms. The insights provided by our work will 47 also benefit future efforts for both industrial strain improvement and novel drug development. 48 49 Main Text: Mycophenolic acid (MPA), which was discovered from Penicillium brevicompactum 50 in 1893 (1), is the first natural product antibiotic in human history. Today, its different active forms 51 (e.g., CellCept ® by Roche and Myfortic ® by Novartis) have annual sales over $1 billion, owing to 52 their wide use as first-line immunosuppressive drugs to control immunologic rejection during 53 organ transplantations and to treat autoimmune diseases (2, 3). Mechanistically, MPA inhibits 54 inosine-5'-monophosphate dehydrogenase; this enzyme catalyzes a known pathway-regulating 55 step of guanine synthesis, which is essential for lymphocyte proliferation (4). MPA is a 56 tetraketide-terpenoid (TKTP) compound; this family comprises various chemical structures with 57 a wide spectrum of biological activities (SI Appendix, Fig. S1 ), and TKTPs are the largest class of 58 meroterpenoids produced by filamentous fungi (5). Despite both MPA's status as the first natural 59 product antibiotic and the growing number of studies reporting the characterization of fungal 60 TKTP biosynthetic pathways (5-8), a full understanding of MPA biosynthesis has remained elusive 61 for more than a century. This knowledge gap is especially conspicuous when one considers that 62 the industrial fermentation of MPA has been established for decades and its structure is not 63 particularly complex, with a full synthesis having been demonstrated by 1969 (9). 64 The first insights into MPA biosynthesis, which were gained more than four decades ago from 65 culture feeding studies using synthetic radioactive isotope labeling precursors, revealed its 66 skeleton is derived from 5-methylorsellinic acid (5-MOA) and farnesyl pyrophosphate (FPP), and 67 a putative oxidative cleavage of the sesquiterpene (C15) side chain (10-12). The C-methyl group at 68 C6 and the O-methyl group at C5 were proposed to originate from S-adenosyl-L-methionine (SAM) 69 (10, 13) . However, the genetic and enzymological bases for MPA biosynthesis remained obscure 70 until the recent independent discoveries of three analogous MPA biosynthetic gene clusters (SI 71 Appendix, Fig. S2 ) (14-16). Upon identification of these clusters, a sub-set of the MPA biosynthetic 72 pathway steps have been revealed through the functional characterization of three biosynthetic 73 enzymes: MpaC (14, 17) and MpaDE (18) from P. brevicompactum IBT23078 as well as MpaG' 74 from P. brevicompactum NRRL864 (Pb864) (15) ( Fig. 1 ). 75 Using examples from the mpa' gene cluster of Pb864 (SI Appendix, Table S1 ) to illustrate the 76 present state of knowledge about MPA biosynthesis ( Fig. 1) : it is known that the MpaC' enzyme 77 is a polyketide synthase (PKS) that catalyzes the formation of its 5-MOA product from one acetyl- Table S2 ) harboring strain AoM-2-3-mpaA' (SI Appendix, Table S3 ), the 99 precursor DHMP was completely converted into a much more hydrophobic product within 5 d 100 ( Fig. 2A ), and analysis of high-resolution mass spectrometry (HRMS) data suggested that the 101 molecular formula of this product was C24H32O4 (SI Appendix, Fig. S8 and Table S4 ), which is 102 consistent with that of FDHMP. NMR analyses further structurally confirmed the product as 103 FDHMP 20-22 . (SI Appendix, Figs. S9-S10 and Table S6 ). 104 Notably, FDHMP was only detected in the extracts prepared from mycelia, but not the 105 fermentation broth ( Fig. 2A ), suggesting that FDHMP might have difficulty in passing through the 106 fungal cell membrane, owing perhaps to its presumably membrane-embedded nature (like FPP) 107 (24). Thus, MpaA' does catalyze the transfer of a farnesyl group from FPP to DHMP via C-C bond 108 formation. However, 5-MOA was not farnesylated in a similar feeding experiment (SI Appendix, Having experimentally confirmed the farnesyl-transfer activity of MpaA', we next attempted 111 to unravel the long-standing biosynthetic mystery of which biomolecule(s) are responsible for the 112 assumed oxidative cleavage of the central double bond in the sesquiterpene chain of FDHMP (i.e., 113 the C15=C16 olefin) (1, 14, (20) (21) (22) (23) . Additional genes of the mpa' gene cluster include mpaF', 114 mpaB', and mpaH'; we did not pursue MpaF' as a candidate for oxidative cleavage functionality 115 because it is known to be an inosine-5'-monophosphate dehydrogenase involved in the self-116 resistance of MPA producing strains (14, 25) . To investigate the unknown functions of MpaB' and 117 MpaH', we used a split-marker recombination strategy (26) to singly knock out mpaB' or mpaH' 118 in Pb864 (SI Appendix, Fig. S12 ) to produce the inactivation mutants Pb864-ΔmpaB' and Pb864- 119 ΔmpaH' (SI Appendix, Table S3 ). 120 Compared to Pb864, Pb864-ΔmpaB' produced a dramatically decreased amounts of MPA, but 121 this strain accumulated a significant amount of FDHMP in its mycelia during a 7 d cultivation 122 using potato dextrose broth (Fig. 2B ). Additionally, a new product was detected in the intracellular 123 fraction of Pb864-ΔmpaB', whose structure was determined as 5-O-methyl-FDHMP (MFDHMP, Table S4 ) and NMR analyses (SI Appendix, Figs. S13-125 S17 and Table S6 ). We reason that the inactivation of MpaB' blocked the normal conversion of 126 FDHMP, which was methylated to MFDHMP (likely by MpaG', which has been reported to 127 display considerable substrate flexibility (15)). Of note, the small amount of MPA produced by 128 Pb864-ΔmpaB' (Fig. 2B ) suggests the existence of minor compensating enzymatic activity for 129 MpaB' in Pb864. 130 To further elucidate the functionality of MpaB', FDHMP (20 mg/L) was fed to an induction 131 culture of AoM-2-3-mpaB' (SI Appendix, Table S3 ). Surprisingly, no obvious products were detected 132 (SI Appendix, Fig. S18 ). We reason that this negative result might be due to the difficulty for 133 FDHMP to enter the intracellular space, which is supported by our earlier observation that FDHMP 134 was not secreted outside of AoM-2-3-mpaA' cells ( Fig. 2A ). To overcome this issue, the recombinant 135 strain AoM-2-3-mpaA'-mpaB' was generated and cultured in CD medium supplemented with 136 maltose to induce the co-expression of MpaA' and MpaB' for 3 d, to which DHMP (20 mg/L) was 137 added. Upon an additional 5 d cultivation, an intermediate with three fewer carbon atoms than 138 FDHMP was observed (Fig. 2C) , purified, and structurally identified as FDHMP-3C ( Fig. 1; SI   139 Appendix, Figs. S8, S19-S23, and Tables S4 and S7 ). Interestingly, FDHMP-3C was previously 140 proposed as a putative intermediate en route to MPA (SI Appendix, Fig. S24 ) (12, 21) . 141 We also found that AoM-2-3-mpaA'-mpaB' produced additional derivatives with UV 142 absorption spectra similar to those of FDHMP and FDHMP-3C ( Fig. 2C ), which presumably 143 derived from FDHMP; these were therefore deemed FDHMP-d1-d5. Structural determination (SI 144 Appendix, Figs. S8, S25-S39, and Tables S4, S7-S8) showed that FDHMP-d1-d5 appear to be 145 chain-shortening intermediates of FDHMP-3C that also bear some additional modifications, 146 suggesting a possible biodegradation pathway through which FDHMP-3C may undergo a 147 oxidation process in which a C2/C3 unit can be successively lost over repeated rounds (Fig. 1) . 148 Strikingly, a small amount of DMMPA was also detected, giving an initial hint that mpaH' may 149 not be a required gene for DMMPA production. 150 These results collectively establish that it is MpaB' which functions as an oxygenase to 151 mediate the oxidative cleavage of the C19=C20 double bond in FDHMP to yield FDHMP-3C. Recall 152 that there are no reports of any known function for MpaB'; and we did not identify any obvious Fig. S24 ). 170 Next, HPLC analysis of the fermentation culture of an aforementioned Pb864-ΔmpaH' strain 171 led to the surprising finding that this mpaH' knockout strain retained the ability to produce MPA, 172 albeit with a yield which was approximately 50% lower than that of Pb864. This mutant strain also 173 produced two novel compounds (MFDHMP-d4 and MFDHMP-d5) with an even shorter isoprenyl 174 chain than MPA (Fig. 1, SI Appendix, Figs. S8, S45 -S51, and Tables S4 and S9); these correspond 175 to the 5-O-methylated products of FDHMP-d4 and FDHMP-d5, presumably stemming from the 176 activity of MpaG' (Fig. 2B) . Notably, neither compound was detected in Pb864 cultures (Fig. 2B) . 177 The attenuated production of MPA, together with the two over-shortening products by Pb864- mpaA'-mpaB'-mpaH' was significantly higher than that of AoM-2-3-mpaA'-mpaB' (Fig. 2C and D) , 189 again emphasizing the importance of MpaH' for efficient production of either DMMPA or MPA. 190 Notably, whereas we were expecting to only detect the accumulation of DMMPA by AoM-2-3-191 mpaA'-mpaB'-mpaH' as the dominant MPA production by Pb864, we were surprised to observe 192 substantial amounts of FDHMP-d1-d3 as well as low levels of FDHMP-d4, d5; note that the 193 methylated counterparts MFDHMP-d1-d5 were only detected at negligible levels in Pb864. We 194 speculate that these differences between Penicillium and Aspergillus species could perhaps be due Tables S2 and S3 ). As 210 anticipated, we observed co-localization of the RFP SKL reporter with the GFP-MpaH' full-length but 211 not the GFP-MpaH' ΔGKL fusion proteins (Fig. 3A-D and SI Appendix, Fig. S53 ). Additionally, 212 feeding experiments demonstrated that the peroxisomal localization of MpaH' increases the 213 efficiency of DMMPA production; specifically, significantly more DMMPA was accumulated in 214 the DHMP-fed AoM-2-3-mpaA '-mpaB'-mpaH' cultures than in the corresponding AoM-2-3-mpaA'-215 mpaB '-mpaH' △ GKL cultures (Fig. 2C and D) . 216 In line with our proposed "valve" function of the peroximal protein MpaH', the fact that 217 fungal -oxidation of long-chain acyl moieties acids can occur in peroxisomes (31, 32), together 218 with our observation of the suspected -oxidation-derived chain-shortening products in the Pb864-
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ΔmpaH' and AoM-2-3-mpaA'-mpaB'/DHMP cultures (Fig. 2) Appendix, Fig. S55 ). Analysis using Phyre2 revealed a likely structural relationship between MpaH' 226 and the peroxisomal hydrolase Lpx1 from S. cerevisiae (33), and careful protein sequence analysis 227 (SI Appendix, Fig. S56 ) suggested that MpaH' is a new member of the type I acyl-CoA thioesterase 228 enzyme family. MpaH' possesses a well-recognized catalytic triad of S139-D163-H365 (34). To 229 confirm that S139 is a catalytic nucleophile, we mutated this serine into an alanine and, as expected, 230 the hydrolytic activity of the MpaH' S139A mutant for either MPA-CoA or DMMPA-CoA was 231 completely abolished (SI Appendix, Fig. S55 ). 232 We subsequently analyzed the steady-state kinetics of MpaH' in vitro using the 5,5-dithiobis-
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(2-nitrobenzoic acid) reagent (35) and found that the kcat/Km values of MpaH' for both CoA (11.6 µM -1 min -1 ) and MPA-CoA (81.5 µM -1 min -1 ) were two orders of magnitude higher 235 than the values for the ten other unnatural CoA-esters that we tested in similar assays (SI Appendix, 236 Fig. S57 and Table S10 ). Thus, our results strongly suggest that MpaH' is a dedicated MPA-CoA 237 hydrolase with high substrate specificity, and this enzyme apparently exerts a valve-like function 238 to prevent MPA-CoA from further peroxisomal -oxidation and to avoid the hydrolysis of other 239 CoA-esters. 240 The 6.2-fold higher kcat/Km value of MPA-CoA relative to DMMPA-CoA suggests (SI 241 Appendix, Table S10 ) that the 5-O-methylation mediated by the methyltransferase MpaG' likely 242 occurs prior to FDHMP-3C's entry into peroxisomes. Supporting this, FDHMP-3C was found to 243 be a better substrate for MpaG' as compared to other potential substrates including DMMPA, 244 FDHMP, 5-MOA, and DHMP (SI Appendix, Fig. S58 ). However, we cannot exclude the 245 possibility that DMMPA methylation could also occur in vivo as a minor pathway ( Figs. 1 and 4) . alter the catalytic properties of these enzymes. 272 In this study, we elucidate the previously unknown steps of the full MPA biosynthetic 273 pathway. The insights gained in our work will benefit future efforts for both industrial strain 274 improvement and novel drug development. The intriguing compartmentalization of the MPA 275 biosynthetic enzymes (Fig. 4) , including the cytosolic MpaC' and MpaG', the inner membrane- 
